about
Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation functionMicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAsIntroducing infectious agents and cancerViral expression associated with gastrointestinal adenocarcinomas in TCGA high-throughput sequencing data.Does the correlation between EBNA-1 and p63 expression in breast carcinomas provide a clue to tumorigenesis in Epstein-Barr virus-related breast malignancies?Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.Genotype distribution of human papillomavirus (HPV) and co-infections in cervical cytologic specimens from two outpatient gynecological clinics in a region of southeast SpainJC virus mediates invasion and migration in colorectal metastasis.Intestinal dysplasia induced by simian virus 40 T antigen is independent of p53.Pathogen-driven cancers and emerging immune therapeutic strategies.Interactions with pocket proteins contribute to the role of human papillomavirus type 16 E7 in the papillomavirus life cycle.Activation of c-Myc and Cyclin D1 by JCV T-Antigen and β-catenin in colon cancer.Viral carcinogenesis: factors inducing DNA damage and virus integrationInduction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell proliferation in a p53-independent manner.Sensitive detection of viral transcripts in human tumor transcriptomes.Simian virus 40 sequences and expression of the viral large T antigen oncoprotein in human pleomorphic adenomas of parotid glands.Alternative signaling pathways: when, where and why?Kaposi's sarcoma and its associated herpesvirus.Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer.BK virus and human cancer: innocent until proven guilty.Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regionsFallen angels or risen apes? A tale of the intricate complexities of imbalanced immune responses in the pathogenesis and progression of immune-mediated and viral cancers.Next generation sequencing and its applications in HPV-associated cancers.Why do viruses cause cancer? Highlights of the first century of human tumour virology.FTS (fused toes homolog) a novel oncoprotein involved in uterine cervical carcinogenesis and a potential diagnostic marker for cervical cancer.Apoptin nucleocytoplasmic shuttling is required for cell type-specific localization, apoptosis, and recruitment of the anaphase-promoting complex/cyclosome to PML bodies.The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle.Demonstration of Herpes Simplex Virus, Cytomegalovirus, and Epstein-Barr Virus in Colorectal Cancer.A Review of Immune Therapy in Cancer and a Question: Can Thermal Therapy Increase Tumor Response?Prevalence of JC polyomavirus large T antigen sequences among Iranian patients with central nervous system tumors.High-risk human papillomavirus infection in different histological subtypes of renal cell carcinoma.Virus like particles as a platform for cancer vaccine development.Viral Oncology: Molecular Biology and Pathogenesis.The site of infection and ethnicity of the patient influence the biological pathways to HPV-induced mucosal cancer.A multi-center survey of age of sexual debut and sexual behavior in Chinese women: suggestions for optimal age of human papillomavirus vaccination in China.Role of Pattern Recognition Receptors in KSHV Infection.
P2860
Q24545850-ED631E99-57A9-425F-91C6-8070CDE067A3Q24655611-48D607D7-A000-4CE6-AD11-71A6D2616290Q30486023-57E8E3EC-754A-4CA3-B2C2-17B9DB50DA1EQ30702069-0C6693F9-BC23-4083-A068-88B881CAD5E4Q33196163-08DE463B-651B-4E91-AFD8-CB652A698F64Q33278623-16708E9A-2C75-412F-ABC8-C9D9E9997324Q33491832-844614FF-A2E1-4E3B-AEE3-2CAA5FA0CB23Q33517629-F9790AD7-8AA4-4E79-8176-98174ACB6F51Q33843097-C405B55F-6924-4AE4-9A0C-5F9744BCB4F5Q34054175-7B3500A5-1343-40F7-B9B7-E1536E4D7D4DQ34142741-D5E00B6A-5707-4F97-8C47-6E544D85ACBBQ34205870-5442D4DC-D107-4969-AEAC-E840F873F711Q34774880-3B6143CD-B3FF-4A40-9326-EE88A3340141Q34817143-C4060593-5B93-45CC-BA13-16F332CB5D6FQ35008736-27232A18-AD09-4FC1-8DA5-1626B078A9FEQ35789188-C5346F21-6857-4DDE-8563-A3A0BBAA1697Q36272217-44437F70-609A-4385-8435-1D4E84CE1BE4Q36487309-C63E7A06-C64F-40E5-8428-31310D53996EQ36611879-A2CDD07A-33D1-455C-AFC4-3B87EC4E21F6Q37223438-8B610588-476A-4C17-B430-559F72AE094AQ37287479-E67E8BAB-2499-4AD8-932B-DF213184EF47Q37620568-A67BCC12-1102-4F85-948F-AECDA58D025FQ37702829-4D5D16DD-658E-4EF9-9DDF-2B24C55099B1Q37811898-56CF8F17-18D4-49C9-88C6-EBD1E556A06FQ39644388-4EE0AB4A-9B9A-4B23-AB16-DE6303158C7CQ40255991-E63EC332-0EC3-466D-A1FC-FB2B9BC32D5DQ40446848-05FFB54D-261D-4BFF-ACFE-F090C293A4B0Q40854748-E768C828-ACBD-4F47-8B1C-9D2D0AA56F1AQ41928232-2B2AE9E3-4A0A-4D7D-9CE9-29EA96608C54Q42188652-0B8187E6-3E9D-43CB-B971-6C43579C9A28Q42226942-7E81096E-2C41-4B56-A89A-933DC7F66A45Q45324534-28FAD857-2943-4F93-8177-6AC9F206C4E0Q47571734-E8737CED-B8F8-4FD9-8A15-C688043D4D46Q47604643-D572CCCF-B485-4DB7-93CE-45D1776E6652Q51356513-911CFE5C-8FCF-4678-98C9-7C4F60F9A7A9Q55338587-1AE7FF69-2B22-47C7-9C68-FDFEADB247AF
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Oncogenic DNA viruses.
@ast
Oncogenic DNA viruses.
@en
Oncogenic DNA viruses.
@nl
type
label
Oncogenic DNA viruses.
@ast
Oncogenic DNA viruses.
@en
Oncogenic DNA viruses.
@nl
prefLabel
Oncogenic DNA viruses.
@ast
Oncogenic DNA viruses.
@en
Oncogenic DNA viruses.
@nl
P2860
P356
P1433
P1476
Oncogenic DNA viruses.
@en
P2860
P2888
P304
P356
10.1038/SJ.ONC.1204958
P407
P577
2001-11-01T00:00:00Z
P5875
P6179
1040392290